Tyra Biosciences CEO Todd Harris' 2023 pay jumps 102% to $4.6M

Tyra Biosciences reports 2023 executive compensation

By ExecPay News

Published: April 18, 2024

Tyra Biosciences reported fiscal year 2023 executive compensation information on April 18, 2024.
In 2023, three executives at Tyra Biosciences received on average a compensation package of $3.5M, a 64% increase compared to previous year.
Average pay of disclosed executives at Tyra Biosciences
Todd Harris, Chief Executive Officer, received $4.6M in total, which increased by 102% compared to 2022. 77% of Harris' compensation, or $3.6M, was in option awards. Harris also received $456K in non-equity incentive plan, $608K in salary, as well as $950 in other compensation.
Alan Fuhrman, Chief Financial Officer, received a compensation package of $3.5M. 78% of the compensation package, or $2.8M, was in option awards.
Hiroomi Tada, Chief Medical Officer, earned $2.4M in 2023, a 90% increase compared to previous year.

Related executives

Todd Harris

Tyra Biosciences

Chief Executive Officer

Alan Fuhrman

Tyra Biosciences

Chief Financial Officer

Hiroomi Tada

Tyra Biosciences

Chief Medical Officer

You may also like

Source: SEC filing on April 18, 2024.